Join to access to all OVN content. Join for Free
SUPER MSL: The Quest to Become the TOP MSL on Your Team
MSL differentiators Super MSL qualities MSL skills Medical Science Liaison success MSL team leadership

SUPER MSL: The Quest to Become the TOP MSL on Your Team


Share This Article


Summary

Daniel Snyder, Senior Medical Affairs & HEOR Leader, discusses the differentiators for MSLs that will make you stand out and become the top MSL on your team. 

Learn more about…

👉 The qualities and differentiators of a “Super MSL”
👉 The skills and attributes that make MSLs stand out relative to their peers
👉 What common mistakes do MSLs need to avoid to
👉 What MSL Team leader should do to encourage and entice ideal MSL skills

Click for Source
MSL differentiators, Super MSL qualities, MSL skills, Medical Science Liaison success, MSL team leadership

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges
Partner Avatar MSL Talk: Tom Caravela, Stephanie Otis

The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges

Podcast
Business Acumen: The Other MSL Currency
Partner Avatar MSL Talk: Tom Caravela, Maria Abunto, Nabhan Islam

Business Acumen: The Other MSL Currency

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Explore OVN